As Amazon (AMZN) ventures further into health care, the online giant may have to work harder to gain consumer trust in a market characterized by a heavy emphasis on patient privacy, at least based on recent actions allegedly taken by its PillPack subsidiary.

Over the past year, PillPack has been accused in different lawsuits of violating federal law by calling or texting consumers to solicit business, a practice that has prompted regulators to take a tougher stand against unwanted marketing. And in one suit, PillPack is attempting to force a consumer to settle her claim in arbitration, a stance that is unlikely to be seen as friendly toward potential customers. Both claim privacy was invaded.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy